-
1دورية أكاديمية
المؤلفون: Atluri H; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Gerstein YS; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. cdinardo@mdanderson.org.
المصدر: Current hematologic malignancy reports [Curr Hematol Malig Rep] 2022 Dec; Vol. 17 (6), pp. 275-285. Date of Electronic Publication: 2022 Oct 24.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 101262565 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-822X (Electronic) Linking ISSN: 15588211 NLM ISO Abbreviation: Curr Hematol Malig Rep Subsets: MEDLINE
-
2دورية أكاديمية
المؤلفون: Ragon BK; Department of Hematologic Oncology and Blood Disorders, The Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard Unit 428, Houston, TX, 77030, USA. CDiNardo@mdanderson.org.
المصدر: Current hematologic malignancy reports [Curr Hematol Malig Rep] 2017 Dec; Vol. 12 (6), pp. 537-546.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 101262565 Publication Model: Print Cited Medium: Internet ISSN: 1558-822X (Electronic) Linking ISSN: 15588211 NLM ISO Abbreviation: Curr Hematol Malig Rep Subsets: MEDLINE
مواضيع طبية MeSH: Isocitrate Dehydrogenase/*genetics , Leukemia, Myeloid, Acute/*drug therapy, Humans ; Leukemia, Myeloid, Acute/pathology ; Mutation